162 related articles for article (PubMed ID: 24639346)
1. Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells.
Rosborough BR; Mathews LR; Matta BM; Liu Q; Raïch-Regué D; Thomson AW; Turnquist HR
J Immunol; 2014 Apr; 192(8):3470-3. PubMed ID: 24639346
[TBL] [Abstract][Full Text] [Related]
2. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice.
Masten BJ; Olson GK; Kusewitt DF; Lipscomb MF
J Immunol; 2004 Apr; 172(7):4077-83. PubMed ID: 15034019
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
4. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
Cohen PA; Koski GK; Czerniecki BJ; Bunting KD; Fu XY; Wang Z; Zhang WJ; Carter CS; Awad M; Distel CA; Nagem H; Paustian CC; Johnson TD; Tisdale JF; Shu S
Blood; 2008 Sep; 112(5):1832-43. PubMed ID: 18577706
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.
Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G
J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701
[TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE
Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320
[TBL] [Abstract][Full Text] [Related]
7. STAT3 is required for Flt3L-dependent dendritic cell differentiation.
Laouar Y; Welte T; Fu XY; Flavell RA
Immunity; 2003 Dec; 19(6):903-12. PubMed ID: 14670306
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
[TBL] [Abstract][Full Text] [Related]
9. VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms.
Zhang K; Zakeri A; Alban T; Dong J; Ta HM; Zalavadia AH; Branicky A; Zhao H; Juric I; Husich H; Parthasarathy PB; Rupani A; Drazba JA; Chakraborty AA; Ching-Cheng Huang S; Chan T; Avril S; Wang LL
Cell Rep; 2024 Jan; 43(1):113661. PubMed ID: 38175754
[TBL] [Abstract][Full Text] [Related]
10. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
[TBL] [Abstract][Full Text] [Related]
11. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
Zhou J; Qu Z; Sun F; Han L; Li L; Yan S; Stabile LP; Chen LF; Siegfried JM; Xiao G
Cancer Immunol Res; 2017 Mar; 5(3):257-268. PubMed ID: 28108629
[TBL] [Abstract][Full Text] [Related]
12. Conditional expression of murine Flt3 ligand leads to expansion of multiple dendritic cell subsets in peripheral blood and tissues of transgenic mice.
Manfra DJ; Chen SC; Jensen KK; Fine JS; Wiekowski MT; Lira SA
J Immunol; 2003 Mar; 170(6):2843-52. PubMed ID: 12626534
[TBL] [Abstract][Full Text] [Related]
13. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
14. Porcine Flt3 ligand and its receptor: generation of dendritic cells and identification of a new marker for porcine dendritic cells.
Guzylack-Piriou L; Alves MP; McCullough KC; Summerfield A
Dev Comp Immunol; 2010 Apr; 34(4):455-64. PubMed ID: 20015454
[TBL] [Abstract][Full Text] [Related]
15. Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells.
Singh P; Hoggatt J; Hu P; Speth JM; Fukuda S; Breyer RM; Pelus LM
Blood; 2012 Feb; 119(7):1671-82. PubMed ID: 22110249
[TBL] [Abstract][Full Text] [Related]
16. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma.
Abad C; Nobuta H; Li J; Kasai A; Yong WH; Waschek JA
J Leukoc Biol; 2014 Feb; 95(2):357-67. PubMed ID: 24068730
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
Sinha P; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development.
Tsapogas P; Swee LK; Nusser A; Nuber N; Kreuzaler M; Capoferri G; Rolink H; Ceredig R; Rolink A
Haematologica; 2014 Apr; 99(4):638-46. PubMed ID: 24463214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
